comparemela.com

Latest Breaking News On - Gerhard orgonas - Page 2 : comparemela.com

CTS Eventim at record high after analysts reactions to outlook

Optimistic signals and a higher dividend from the previous day continue to have an effect at CTS Event im on Wednesday. In the meantime, several analysts have raised their price targets for the shares.

REDCARE PHARMACY : Berenberg maintains a Buy rating -March 12, 2024 at 03:25 am EDT

In his latest research note, analyst Gerhard Orgonas confirms his positive recommendation. The broker Berenberg is keeping its Buy rating. The target price is unchanged at EUR 190.

CTS EVENTIM : Gets a Buy rating from Berenberg -February 08, 2024 at 02:05 am EST

In a research note published by Gerhard Orgonas, Berenberg advises its customers to buy the stock. The target price has been raised from EUR 85 to EUR 90.

DOCMORRIS : Raised to Buy by Berenberg -January 05, 2024 at 02:16 am EST

Berenberg s analyst Gerhard Orgonas upgrades his rating from Neutral to Buy. Previously set at CHF 60, the target price has been raised to CHF 100.

DERMAPHARM : Berenberg reaffirms its Buy rating -December 07, 2023 at 09:57 am EST

In a research note published by Gerhard Orgonas, Berenberg advises its customers to buy the stock. The target price continues to be set at EUR 58.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.